MedTrace Logo

Teaching: Individual to Increase Adherence to Therapeutic Regimen in Hypertension Arterial and/or Diabetes Type 2

NCT02758275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-10-19

No results posted yet for this study

Summary

The purpose of this study is to improve the adherence of therapeutic regimen in people with hypertension arterial and/or diabetes mellitus type 2. Our hypothesis is the nursing intervention "Teaching: Individual", is more effective to increase adherence of therapeutic regimen in people with hypertension arterial and/or diabetes mellitus type 2, than usual care.

Conditions

Interventions

BEHAVIORAL

Teaching: Individual (5606)

Usual care and Teaching: Individual (5606): It consists of 6 educational sessions: 1. Behavior Modification (4360) Promotion of a behavior change. 2. Teaching Disease Process (5602) Assisting the patient to understand information related to a specific disease process. 3. Teaching: Prescribed Medication (5616) Preparing a patient to safely take prescribed medications and monitor for their effects. 4. Teaching: Prescribed Diet (5614) Preparing a patient to correctly follow a prescribed diet. 5. Teaching: Prescribed Exercise (5612) Preparing a patient to achieve and/or maintain a prescribed level of activity. 6. Coping Enhancement (5230) Assisting a patient to adapt to perceived stressors, changes, or threats that interfere with meeting life demands and roles.

Sponsors & Collaborators

  • Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)

    collaborator OTHER_GOV

  • Cardiecol

    collaborator UNKNOWN

  • Instituto de Salud de Bucaramanga

    collaborator OTHER

  • Universidad Industrial de Santander

    lead OTHER

Principal Investigators

  • Sandra Lucrecia SL Romero Guevara, MSc Nursing · Universidad Industrial de Santander

  • Dora Inés DI Parra, MSc Nursing · Universidad Industrial de Santander

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-28
Primary Completion
2016-07-21
Completion
2017-09-15

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758275 on ClinicalTrials.gov